Autolus Therapeutics plc
AUTL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001730463
In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Autolus Therapeutics plc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 66 | 1 | 71 | +6 |
| Shares | 49.4M | 16.9K | 107.5M | +58.1M (+117.8%) |
| Value | $105.7M | $36.2K | $204.2M | +$98.5M (+93.3%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Autolus Therapeutics plc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 15,000,000 | $28.5M | 1.24% |
| Armistice Capital, LLC | 10,224,000 | $19.4M | 0.52% |
| Odey Asset Management Group Ltd | 2,499,400 | $4.75M | 1.43% |
| Laurion Capital Management LP | 1,500,000 | $2.85M | 0.08% |
| Alyeska Investment Group, L.P. | 1,464,300 | $2.78M | 0.03% |
| CVI Holdings, LLC | 1,237,511 | $2.35M | 0.30% |
| Sphera Funds Management Ltd. | 500,000 | $950.0K | 0.30% |
| Pentwater Capital Management LP | 400,000 | $760.0K | 0.02% |
| Caas Capital Management LP | 322,795 | $613.3K | 0.12% |
| Ergoteles LLC | 169,180 | $321.4K | 0.01% |
| Leonteq Securities AG | 100,000 | $190.0K | 0.01% |
| Covalis Capital LLP | 67,767 | $128.8K | 0.03% |
| Two Sigma Investments, LP | 33,700 | $64.0K | 0.00% |
| Acadian Asset Management LLC | 22,025 | $40.0K | 0.00% |
| Alpine Global Management, LLC | 19,885 | $38.0K | 0.01% |
| SEI Investments Co | 15,040 | $28.6K | 0.00% |
| CI Private Wealth, LLC | 15,000 | $28.5K | 0.00% |
| Squarepoint Ops LLC | 10,407 | $19.8K | 0.00% |
| United Bank | 10,300 | $19.6K | 0.00% |
| Lazard Asset Management LLC | 3,752 | $7.00K | 0.00% |
| Lindbrook Capital, LLC | 1,935 | $3.68K | 0.00% |
Sold out (15)
Institutions that held Autolus Therapeutics plc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| UBS Oconnor LLC | 584,406 | $1.25M |
| Woodline Partners LP | 428,255 | $916.0K |
| MYDA Advisors LLC | 100,000 | $214.0K |
| Kettle Hill Capital Management, LLC | 89,792 | $192.0K |
| Caxton Associates LP | 84,156 | $180.0K |
| Legal & General Group Plc | 67,517 | $146.0K |
| Alps Advisors Inc | 49,657 | $106.0K |
| Gsa Capital Partners LLP | 22,885 | $49.0K |
| Northeast Financial Consultants Inc | 19,672 | $42.0K |
| Jane Street Group, LLC | 19,289 | $41.0K |
| Goldman Sachs Group Inc | 18,851 | $40.0K |
| Weiss Multi-Strategy Advisers LLC | 13,324 | $29.0K |
| US Bancorp | 7,652 | $16.0K |
| China Universal Asset Management Co., Ltd. | 542 | $1.00K |
| Daiwa Securities Group Inc. | 74 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Autolus Therapeutics plc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| American Portfolios Advisors | 16,925 | $36.2K |